Not feeling appetite suppression on Mounjaro — what it means and what comes next

Mounjaro's appetite effect works through two gut-hormone receptors (GIP and GLP-1); how strongly each responds varies from person to person and dose to dose.
2.5mg is a tolerability dose — its job is to settle your system, not to deliver the full therapeutic effect.
Appetite suppression often appears or deepens after the first or second dose increase, typically from weeks four to eight onwards.
Persistent lack of any appetite change at a higher dose is worth discussing with your prescriber before making any changes to your treatment.

If Mounjaro isn't suppressing your appetite the way you expected, you're not imagining things, and you're not alone. Appetite reduction on tirzepatide varies considerably between people, particularly in the first few weeks. Some patients notice it almost immediately; others feel very little difference at 2.5mg and only begin to experience it after a dose increase. Understanding why that happens (and what your options are) is the real question worth answering here.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to think through what's happening, and what to do about it

Is it actually suppressing your appetite, just not in the way you pictured?

Many people arrive on Mounjaro expecting a clear, dramatic signal, a sudden disinterest in food, perhaps the inability to finish a plate. For some, that's exactly what happens. For others, the effect is quieter: fewer thoughts about food between meals, smaller portions feeling satisfying, snacking that simply… stops. If you've been waiting for a Hollywood moment and it hasn't come, it's worth pausing to check whether something subtler is already at work.

A useful exercise is tracking meals for a week without trying to change them. You may find you're naturally eating less than you were before treatment, even if hunger hasn't vanished. That low-level shift is still the medicine doing its job. The way tirzepatide affects appetite is not always the abrupt suppression people read about online, it can be a gradual recalibration rather than a hard off-switch.

That said, if you genuinely feel no different at all (same hunger, same portion sizes, same cravings) that's a meaningful signal, and the sections below cover why it can happen and what the decision points are.

Why the first pen often feels like nothing much happened

The starting dose of Mounjaro (2.5mg) exists for one reason: to give your body time to adjust before the dose that actually does the heavy lifting. Most people find that appetite suppression is modest or absent at this stage, and that's by design. It would be clinically premature to judge whether tirzepatide is working for you based on those first four weeks alone.

The NHS notes that tirzepatide is titrated gradually, with dose increases typically every four weeks as directed by a prescriber. Each step up tends to bring a stronger effect on appetite regulation. Many patients who felt little at 2.5mg report a noticeable shift after moving to 5mg or 7.5mg. If you want a clearer picture of when appetite suppression typically begins, the timeline is usually tied more closely to dose level than to weeks on treatment.

One thing our prescribers hear regularly: patients who were ready to stop after the first pen, then found the effect arrived properly at the second or third dose. Timing matters here, and patience at the beginning is often rewarded.

Factors that can blunt appetite suppression even at a higher dose

If you're past the starter dose and still not noticing much reduction in appetite, several factors are worth considering. None of them mean the medicine has failed, they mean the picture needs looking at more carefully.

What you're eating. Ultra-processed foods, particularly those high in refined sugar and fat, can partially work around the satiety signals tirzepatide produces. The medicine slows gastric emptying and reduces appetite signals, but foods engineered to bypass fullness cues can still override those signals. Shifting towards protein-rich, fibre-dense meals supports the medicine's effect. The foods that work well alongside Mounjaro are worth reading if you haven't already, and if you're curious about specific fruits, our guide on whether pineapple fits into a Mounjaro diet is a useful example of how individual food choices can be assessed. The NHS also covers diet basics for people on weight-management medicines via their Better Health lose weight guidance.

Stress and sleep. Both affect ghrelin and cortisol, hormones that drive hunger. High stress or poor sleep can push appetite upward independently of what tirzepatide is doing, making the medicine's contribution less visible.

Injection technique and timing. Rotating sites (abdomen, thigh, upper arm), making sure the pen is at room temperature before use, and confirming the full dose was delivered all affect how consistently the medicine is absorbed. Your Patient Information Leaflet covers technique in detail, and if anything is unclear, it's worth contacting your prescriber rather than guessing.

Whether suppression has diminished over time. A separate but related issue is appetite suppression that was present and then faded. If that sounds more like your situation, there is specific guidance on appetite suppression wearing off on Mounjaro that covers what to do when it wanes.

The actual decision in front of you, and how a prescriber helps you make it

The core question, if you're experiencing no appetite suppression on Mounjaro, is whether to wait, adjust your lifestyle approach, or discuss a dose review with your prescriber. Only one of those options shouldn't be done alone.

Adjusting your dose (moving up earlier than planned, or considering a change in approach) is a clinical decision that depends on your full medical picture, how long you've been at your current dose, and what your weight trend has been. It's not something to change based on a forum post or a general article, including this one. If you're at 2.5mg and it's been less than four weeks, the most evidence-backed step is simply to wait for the next scheduled increase. If you're at 7.5mg or above and appetite genuinely feels unchanged, that is worth raising directly with your prescriber at your next review, or sooner if you're concerned.

On Mounjaro's treatment page you'll find an overview of the full treatment pathway. If you're not yet on treatment and are wondering whether the medicine would suit you, a free consultation with one of our prescribers is the right starting point. You can check your eligibility without any obligation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions